(Q37575509)

21 August 2017

1 reference

title

Cholesteryl ester transfer protein inhibitors as high-density lipoprotein raising agents (English)

1 reference

21 August 2017

1 reference

Hisashi Shinkai

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Expert Opinion on Therapeutic Patents

21 August 2017

published in

1 reference

21 August 2017

volume

19

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

1229-1237

1 reference

Pharmacotherapy for dyslipidaemia – current therapies and future agents

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

High-density lipoprotein--the clinical implications of recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Oral cholesteryl ester transfer protein (CETP) inhibitors: a potential new approach for treating coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Anacetrapib: new hope for cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Designs of RADIANCE 1 and 2: carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Effect of torcetrapib on the progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

The failure of torcetrapib: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903198451

10.1517/13543770903198451

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference